$4.97
0.040.81%
Últ. Act.: Nov 12, 7:24 AM
Clover Health Investments (CLOV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0.01 | $0.01 | 0.00 % |
| Q2 | Aug 5, 2026 | $0.05 | $0.04 | 25.0 % |
| Q1 | May 6, 2026 | $0.05 | $0.06 | -16.7 % |
| Q4 | Feb 26, 2026 | $-0.10 | $-0.07 | -42.9 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $759.30M | $740.07M | 2.60 % |
| Q2 | Aug 5, 2026 | $743.17M | $728.27M | 2.05 % |
| Q1 | May 6, 2026 | $749.20M | $713.48M | 5.01 % |
| Q4 | Feb 26, 2026 | $487.71M | $469.23M | 3.94 % |
Clover Health Investments (CLOV) publicó su última previsión de noviembre 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $2.97B - $3B para el período.
En comparación con la previsión anterior, Clover Health Investments mantenido redujo su previsión de ingresos desde un rango anterior de $2.92B - $3B.
Clover Health Investments ha emitido 11 actualizaciones de orientación entre el enero 10, 2023 y el noviembre 4, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $0.04 | $0.06 | $-0.07 |
| Actual | $0.01 | $0.05 | $0.05 | $-0.10 |
| Surprise | 0.00% | +25.0% | -16.7% | -42.9% |
| Revenue | ||||
| Estimate | $740.1M | $728.3M | $713.5M | $469.2M |
| Actual | $759.3M | $743.2M | $749.2M | $487.7M |
| Surprise | +2.60% | +2.05% | +5.01% | +3.94% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.03 | $0.08 | $0.06 | $0.04 |
| Revenue | ||||
| Consensus | $730.7M | $915.9M | — | — |